DK385888A - Kapsel med nikotinholdigt flydende medium til oral indtagelse - Google Patents

Kapsel med nikotinholdigt flydende medium til oral indtagelse

Info

Publication number
DK385888A
DK385888A DK385888A DK385888A DK385888A DK 385888 A DK385888 A DK 385888A DK 385888 A DK385888 A DK 385888A DK 385888 A DK385888 A DK 385888A DK 385888 A DK385888 A DK 385888A
Authority
DK
Denmark
Prior art keywords
oral administration
capsule
liquid medium
nicotine
containing liquid
Prior art date
Application number
DK385888A
Other languages
English (en)
Other versions
DK385888D0 (da
DK173353B1 (da
Inventor
Franz Adlkofer
Original Assignee
Forsch Ges Rauchen Gesundheit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forsch Ges Rauchen Gesundheit filed Critical Forsch Ges Rauchen Gesundheit
Publication of DK385888A publication Critical patent/DK385888A/da
Publication of DK385888D0 publication Critical patent/DK385888D0/da
Application granted granted Critical
Publication of DK173353B1 publication Critical patent/DK173353B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK198803858A 1986-11-18 1988-07-08 Kapsel med nikotinholdigt flydende medium til oral indtagelse DK173353B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3639418 1986-11-18
DE19863639418 DE3639418A1 (de) 1986-11-18 1986-11-18 Nikotinhaltiges mittel
PCT/DE1987/000507 WO1988003803A1 (en) 1986-11-18 1987-11-06 Oral administration capsule with a nicotine-containing fluid medium
DE8700507 1987-11-06

Publications (3)

Publication Number Publication Date
DK385888A true DK385888A (da) 1988-07-08
DK385888D0 DK385888D0 (da) 1988-07-08
DK173353B1 DK173353B1 (da) 2000-08-07

Family

ID=6314221

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198803858A DK173353B1 (da) 1986-11-18 1988-07-08 Kapsel med nikotinholdigt flydende medium til oral indtagelse

Country Status (9)

Country Link
EP (1) EP0324794B1 (da)
JP (1) JP2602043B2 (da)
CN (1) CN87107852A (da)
AT (1) ATE72114T1 (da)
AU (1) AU622101B2 (da)
BR (1) BR8707879A (da)
DE (3) DE3639418A1 (da)
DK (1) DK173353B1 (da)
WO (1) WO1988003803A1 (da)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE4440563A1 (de) * 1994-11-12 1996-05-15 Herzog Sen Rolf Verfahren und Mittel zum Genuß von Tabak - Nikotin unter Vermeidung schädlicher Verbrennungs - Derivate
US5604231A (en) * 1995-01-06 1997-02-18 Smith; Carr J. Pharmaceutical compositions for prevention and treatment of ulcerative colitis
US5846983A (en) * 1996-02-09 1998-12-08 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
WO1997034605A1 (en) * 1996-03-21 1997-09-25 Mayo Foundation For Medical Education And Research Use of nicotine to treat liver disease
GB9614902D0 (en) * 1996-07-16 1996-09-04 Rhodes John Sustained release composition
AUPO108596A0 (en) * 1996-07-18 1996-08-08 Collier, Gregory Treatment of obesity
US6211194B1 (en) * 1998-04-30 2001-04-03 Duke University Solution containing nicotine
US6268386B1 (en) * 1998-06-25 2001-07-31 Marshall Anlauf Thompson Nicotine beverage
GB2338896B (en) 1998-07-02 2003-05-21 Reckitt & Colmann Prod Ltd Chewable Capsules
US8188043B2 (en) 1999-07-28 2012-05-29 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
US6417205B1 (en) 1999-07-28 2002-07-09 The Board Of Trustees Of The Leland Stanford Jr. University Nicotine in therapeutic angiogenesis and vasculogenesis
AT409219B (de) * 1999-08-13 2002-06-25 Red Bull Gmbh Verwendung von nikotin zum herstellen von arzneimitteln
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20040002520A1 (en) * 2002-07-01 2004-01-01 Soderlund Patrick L. Composition and method for cessation of Nicotine cravings
DE60313216T2 (de) 2002-12-20 2008-01-03 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
WO2005007068A1 (en) * 2003-07-22 2005-01-27 The Kiwigel Company Limited Nicotine packaging system
NO20042835D0 (no) * 2004-07-05 2004-07-05 Nils-Erik Skeide Innkapslet tobakksroyk
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
EP1802258A4 (en) 2004-09-13 2015-09-23 Chrono Therapeutics Inc BIOSYNCHRONE TRANSDERMAL MEDICINES
JP5694645B2 (ja) 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
GB2448224B (en) * 2007-04-02 2010-09-01 Parkinson S Inst Solid orally administered pharmaceutical composition for the reduction of side-effects of a dopaminergic agent
CN101249130B (zh) * 2008-04-11 2011-06-15 桂林商源植物制品有限公司 一种戒烟并缓解戒烟综合症的药用或保健组合物
EP2729148A4 (en) 2011-07-06 2015-04-22 Parkinson S Inst COMPOSITIONS AND METHODS FOR TREATING SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE
EP3250258A4 (en) 2015-01-28 2018-09-05 Chrono Therapeutics, Inc. Drug delivery methods and systems
JP2018511127A (ja) 2015-03-12 2018-04-19 クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． 渇望入力及び支援システム
EP3297676A2 (en) * 2015-05-22 2018-03-28 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Combination of trpm8-agonist and nachr-agonist for treatment of obesity and related disorders and for weight reduction
CN105341990A (zh) * 2015-12-16 2016-02-24 浙江中烟工业有限责任公司 一种提升电子烟生理满足感的电子烟烟液
CA3049529A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
EP3801732A4 (en) 2018-05-29 2022-04-27 Morningside Venture Investments Limited DRUG DELIVERY METHODS AND SYSTEMS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU432703A3 (da) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
US3870794A (en) * 1974-02-20 1975-03-11 Foundation For Behavioral Rese Treatment of certain emotional disorders with nicotine compounds
GB1528391A (en) * 1976-01-05 1978-10-11 Gildemeister V Aerosol compositions
DE3241437A1 (de) * 1982-11-10 1984-05-10 Ferdinand Prof. Dr.med. 6901 Wilhelmsfeld Schmidt Mittel zum zwecke der raucherentwoehnung und/oder fuer nebenwirkungsfreien nikotingenuss bei suchtrauchern
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
BE899037A (fr) * 1984-02-29 1984-06-18 Trenker Ady Composition a sucer permettant de cesser de fumer
DE3438284A1 (de) * 1984-10-16 1985-03-07 Hans-Harald von 2400 Lübeck Tilly Nikotinhaltiges depotpflaster
EP0186502A3 (en) * 1984-12-25 1986-12-10 Jano Tyroler Flavor capsule and method of preparing same
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment

Also Published As

Publication number Publication date
BR8707879A (pt) 1989-10-03
DE3639418C2 (da) 1989-08-03
DE3776574D1 (de) 1992-03-12
DE3639418A1 (de) 1988-06-09
DE3645036A1 (de) 1989-01-05
AU622101B2 (en) 1992-04-02
AU8171287A (en) 1988-06-16
CN87107852A (zh) 1988-06-22
EP0324794B1 (de) 1992-01-29
EP0324794A1 (de) 1989-07-26
ATE72114T1 (de) 1992-02-15
DK385888D0 (da) 1988-07-08
JP2602043B2 (ja) 1997-04-23
JPH02501304A (ja) 1990-05-10
DK173353B1 (da) 2000-08-07
WO1988003803A1 (en) 1988-06-02

Similar Documents

Publication Publication Date Title
DK385888A (da) Kapsel med nikotinholdigt flydende medium til oral indtagelse
EP0299924A3 (en) Reduced base content chewing gum compositions having anesthetic properties
ES2009915A6 (es) Un procedimiento para preparar una composicion que comprende cefuroximo-axetil en forma de particulas.
GB1315626A (en) Substituted p-menthanes and compositions containing them
EP0146334A3 (en) Chewing tobacco product
DE3864646D1 (de) Tabakportion.
SE8801732L (sv) Ny komposition
DE68906018T2 (de) Verwendung von kakaopulver zur verbesserung des geschmacks von künstlicher kaugummimasse.
ITMI911791A1 (it) Composizioni farmaceutiche per la terapia dell'astinenza, del " craving", della dipendenza da sostanze stupefacenti, da sostanze psicoattive, da nicotina e dei disturbi alimentari.
DE68915163D1 (de) Emulgiermittel zur verlängerung des geschmacks bei kaugummi.
ES8705750A1 (es) Un metodo para la obtencion de una composicion azucarada co-mestible y oral preventora del deterioro dental.
SE8303401D0 (sv) Beredning och dess anvendning
FR2603166B1 (fr) Lait chocolate
GR75738B (da)
JO1560B1 (en) Mouthwash to prevent smoking
ATE56141T1 (de) Festes arzneimittel zur oralen verabreichung.
PL297882A1 (en) Agent facilitating to lose the habit of cigarette smoking
JPS62296840A (ja) たばこキヤンデ−およびシガレツトキヤンデ−
JPS58121755A (ja) カルシウム入りチユ−インガム
JPS5279096A (en) Preparation of improved smoking composition
JPS51136897A (en) Fragrance composition for tobacco
ATE88059T1 (de) Verwendung von kakaopulver zur verbesserung des geschmacks von kuenstlicher kaugummimasse.
BG97912U (en) Means for mouth flavour and disinfestation
IT8660545V0 (it) Portasigarette perfezionato particolarmente per ridurre la quantita' fumata.
JPS53107497A (en) Smoking composition containing 2-hydroxy-beta-ionone as effective component

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK